The U.S. Food and Drug Administration (FDA) today approved Evicel Fibrin Sealant, a liquid product that when applied topically helps control oozing from small blood vessels during surgical procedures.
The effort to contain deadly yellow fever, recently resurgent in West Africa, received a boost today at the annual policy meeting of the United Nations health agency, with the launch of an immunization campaign backed by a $58 million contribution.
Now that the genome sequences of hundreds of bacteria and viruses are known, we can design tests that will rapidly detect the presence of these species based solely on their DNA.
A vaccine that prevents HIV infection remains an important goal in the fight against AIDS, but the current top HIV vaccine candidates may not work in this way, say scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Over 30% of our genes are under the control of small molecules called microRNAs. They prevent specific genes from being turned into protein and regulate many crucial processes like cell division and development, but how they do so has remained unclear.
The outbreak of severe acute respiratory syndrome (SARS) in 2002 was a loud wake-up call for researchers studying infectious diseases. SARS infected over 8,000 people, killed 10 percent of those infected, and weakened most with pneumonia.
The efforts of the Baylor International Pediatric AIDS Initiative expanded in a new direction with the opening of a state-of-the-art laboratory in partnership with and located at the Stefan S. Nicolau Institute of Virology in Bucharest, Romania.
Boehringer Ingelheim GmbH announced that it has initiated and begun enrollment of patients in the ArTEN trial, which will compare the efficacy and safety of Viramune? (nevirapine), a non-nucleoside reverse transcriptase inhibitor (NNRTI), dosed once daily (QD) or twice daily (BID), versus atazanavir/ritonavir, a once-daily dosed protease inhibitor (PI).
Roche announced that the U.S. Food & Drug Administration (FDA) has approved its new HIV-1 test for diagnostic use in the United States. The highly accurate Cobas AmpliPrep/Cobas TaqMan HIV-1 Test is the first fully automated HIV-1 diagnostic tool using real-time PCR technology in the US.
A deadly new fish virus that caused huge fish kills in several eastern Great Lakes in 2005 and 2006 is likely already in Lake Michigan and may be in Lake Superior and the Mississippi River.